Crinetics Pharmaceuticals Inc
NASDAQ:CRNX

Watchlist Manager
Crinetics Pharmaceuticals Inc Logo
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Watchlist
Price: 56.54 USD 1.4% Market Closed
Market Cap: 5.1B USD
Have any thoughts about
Crinetics Pharmaceuticals Inc?
Write Note

Net Margin
Crinetics Pharmaceuticals Inc

-18 613.5%
Current
-5 389%
Average
-7.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-18 613.5%
=
Net Income
-258.5m
/
Revenue
1.4m

Net Margin Across Competitors

Country US
Market Cap 5.1B USD
Net Margin
-18 614%
Country US
Market Cap 358.9B USD
Net Margin
10%
Country US
Market Cap 172.7B USD
Net Margin
10%
Country US
Market Cap 122.8B USD
Net Margin
-5%
Country US
Market Cap 110.7B USD
Net Margin
4%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country US
Market Cap 92B USD
Net Margin
32%
Country AU
Market Cap 138.7B AUD
Net Margin
18%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country US
Market Cap 34.2B USD
Net Margin
-3%
Country NL
Market Cap 32B EUR
Net Margin
-14%

Profitability Report

View the profitability report to see the full profitability analysis for Crinetics Pharmaceuticals Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-18 613.5%
=
Net Income
-258.5m
/
Revenue
1.4m
What is the Net Margin of Crinetics Pharmaceuticals Inc?

Based on Crinetics Pharmaceuticals Inc's most recent financial statements, the company has Net Margin of -18 613.5%.